How to analyze the complex role of the IL-4 Surpass ELISA kit in allergy, infection, and tumor immunity?

I. What are the sources of Interleukin-4 (IL-4) and its central role in type 2 immune responses?

Interleukin-4 (IL-4) is a pleiotropic cytokine primarily produced by activated type 2 helper T cells (Th2), mast cells, and basophils. As a key hub driving type 2 immune responses, IL-4 plays an irreplaceable role in coordinating humoral immunity, allergic reactions, anti-parasitic defense, and certain immunoregulatory processes. Its biological effects are achieved by binding to receptor complexes composed of IL-4Rα and γc chain (or IL-13Rα1), mainly activating the JAK-STAT6 signaling pathway, which broadly regulates the function, differentiation, and survival of various immune cells.

II. How does IL-4 precisely regulate B cell activation and antibody class switching?

The regulation of B cell function by IL-4 is one of its most classical roles, profoundly influencing the quality and quantity of humoral immune responses.

1. Promoting activation and proliferation: IL-4 is one of the key early signals for resting B cells to enter the activation cycle (from G0 to G1 phase) and can enhance the proliferative response of B cells to antigen stimulation.

2. Inducing antibody class switching: IL-4 is the core factor driving B cells to undergo immunoglobulin class switching, specifically producing immunoglobulin E (IgE) and immunoglobulin G1 (IgG1). It mediates DNA recombination, promoting B cells to switch from secreting IgM to secreting IgE and IgG1. This mechanism is crucial in allergic diseases (IgE-mediated) and anti-parasitic immunity (IgG1, IgE-mediated).

3. Upregulating key surface molecules: IL-4 can upregulate the expression of major histocompatibility complex class II molecules (MHC II) and CD40 on B cells, enhancing their antigen-presenting capacity; it also upregulates the low-affinity IgE receptor (FcεRII/CD23), whose soluble form (sCD23) further participates in the regulation of IgE production.

IL-4 and γ-interferon (IFN-γ) antagonize each other in this function. IFN-γ promotes IgG2a production while inhibiting IL-4-driven IgE/IgG1 generation, reflecting the balance between type 1 and type 2 immune responses.

III. How does IL-4 regulate immune cells such as T cells and macrophages?

In addition to its core role in B cells, IL-4 broadly regulates the functional states of other immune cells.

1. Regulation of T cells: IL-4 is a key autocrine growth factor for the differentiation and maintenance of Th2 cells while inhibiting the differentiation of Th1 cells, thereby shaping the polarization direction of immune responses. Under certain conditions, it can exhibit inhibitory effects on cytotoxic T lymphocytes (CTL) and natural killer (NK) cell activity.

2. Regulation of macrophages/monocytes: IL-4 induces the differentiation of monocytes into alternatively activated (M2-type) macrophages. These macrophages highly express mannose receptors and scavenger receptors, possessing functions that suppress inflammation, promote tissue repair, and fibrosis, while their antigen-presenting capacity and anti-tumor cytotoxicity may also be altered. IL-4 can also synergize with other cytokines to stimulate monocytes to produce colony-stimulating factors (G-CSF, M-CSF).

3. Effects on mast cells and hematopoietic cells: IL-4 is an essential cytokine for the growth and survival of mast cells in certain tissues (e.g., mucosa). Additionally, it can synergize with other hematopoietic growth factors (e.g., G-CSF, EPO) to promote the proliferation and differentiation of granulocyte and erythroid progenitors.

IV. What dual roles does IL-4 play in disease pathogenesis and treatment?

The biological functions of IL-4 determine its dual roles as both a pathogenic factor and a therapeutic target in various diseases.

1. Allergic diseases: As a key driver of IgE production, IL-4 is a central pathological mediator in allergic asthma, atopic dermatitis, allergic rhinitis, and other conditions. It can also directly stimulate mucus secretion by airway epithelial cells and smooth muscle hyperreactivity.

2. Anti-parasitic immunity: In infections with helminths and other parasites, the IL-4-driven type 2 immune response (including IgE, eosinophils, and M2 macrophages) is an important defense mechanism for host parasite clearance.

3. Inflammation and autoimmunity: Since IL-4 can inhibit the production of pro-inflammatory factors such as tumor necrosis factor-α (TNF-α) and IL-1β by monocytes/macrophages and promote the production of IL-1 receptor antagonist (IL-1ra), it is considered a cytokine with potential anti-inflammatory properties and has been explored in the treatment of sepsis, rheumatoid arthritis, and other diseases.

4. Tumor immunity: Its role is more complex. On one hand, IL-4 may promote tumor growth by fostering immunosuppressive M2 macrophages and inhibiting anti-tumor CTL responses; on the other hand, since many tumor cells express IL-4 receptors, direct use of IL-4 or therapies targeting it (e.g., IL-4 toxin conjugates, receptor antagonists) have been attempted for tumor treatment.

V. Which manufacturers provide IL-4 Surpass ELISA kits?

Hangzhou Start Biotech Co., Ltd. has independently developed the "Human Interleukin-4 (Human IL-4) Enhanced ELISA Antibody Pair Set Kit" (Catalog No.: S0H2012), a core reagent kit meticulously designed for developing high-sensitivity, high-specificity quantitative detection methods for human IL-4. This product provides rigorously paired and validated capture and detection antibody pairs, aiming to help users efficiently construct superior sandwich ELISA detection systems. It is suitable for accurately and reliably quantifying IL-4 levels in various samples such as human serum, plasma, and cell culture supernatants, serving as a key tool for assessing Th2-type immune responses, allergy and humoral immunity research, and drug development.

Professional Technical Support: We provide detailed technical documentation, including specificity validation data for antibody pairs, recommended ELISA setup protocols (coating, blocking, detection conditions), reference buffer formulations, and standard curve establishment guidelines. Our technical team offers professional method development and optimization support.

Hangzhou Start Biotech Co., Ltd. is committed to providing high-performance, high-value core reagents for immunology research, allergic disease fields, and drug development. For more information about the "Human Interleukin-4 (Human IL-4) Enhanced ELISA Antibody Pair Set Kit" (Catalog No. S0H2012), to obtain technical materials, or to request a trial, please feel free to contact us.

Product Information

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.